Clinical Trials for Refractory Primary Malignant Central Nervous System Neoplasm

Find clinical trials for refractory primary malignant central nervous system neoplasm. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

NCT ID: NCT04870944

This clinical trial is studying a new treatment called CBL0137 for young patients with certain types of solid tumors, including cancers of the central nervous system (CNS) and lymphoma that have ei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Philadelphia, Pennsylvania, United States +32 more

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

NCT ID: NCT05768880

This clinical trial is studying a new treatment for certain types of brain tumors in children and young adults, specifically diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG), a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions